Toxicity of sorafenib: clinical and molecular aspects.
Blanchet B, Billemont B, Barete S, Garrigue H, Cabanes L, Coriat R, Francès C, Knebelmann B, Goldwasser F.
Blanchet B, et al. Among authors: coriat r.
Expert Opin Drug Saf. 2010 Mar;9(2):275-87. doi: 10.1517/14740330903510608.
Expert Opin Drug Saf. 2010.
PMID: 20078249
Review.